Understanding of chemoprophylaxis and concordance in inflammatory bowel disease

doi:10.3748/wjg.v16.i5.578

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 5

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2413)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-2) series.

Item

Count

PDF

235

HTML

1871

Figures (1-1)

159

Tables (1-2)

148

Sum=2413

Feb 7, 2010 (publication date) through Apr 25, 2024

Times Cited of This Article

Times Cited (4)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Feb 7, 2010; 16(5): 578-582
Published online Feb 7, 2010. doi: 10.3748/wjg.v16.i5.578

Open in New Tab Full Size Figure Download Figure

Figure 1 A comparison of the IBD vs PSC/IBD cohorts. IBD: Inflammatory bowel disease; PSC: Primary sclerosing cholangitis; 5-ASA: 5-aminosalicylic acid; UDCA: Ursodeoxycholic acid.

Citation: Low A, Love M, Walt R, Kane K, Eksteen B, Goh J. Understanding of chemoprophylaxis and concordance in inflammatory bowel disease. World J Gastroenterol 2010; 16(5): 578-582
URL: https://www.wjgnet.com/1007-9327/full/v16/i5/578.htm
DOI: https://dx.doi.org/10.3748/wjg.v16.i5.578